Yahoo Finance 
Professional Acne Treatment Market
From $6,298. 9 million in 2020, the global professional acne treatment market value is predicted to reach $13,124. 5 million by 2030, at a 7. 6% CAGR between 2020 and 2030, according to the market research report published.
New York, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Professional Acne Treatment Market" - https://www.reportlinker.com/p06180058/?utm_source=GNW
Key findings of this study
• Treatments via devices to become rapidly popular in coming years
• Professional treatment sought more commonly for inflammatory acne
• Strong drug pipeline key driver for market growth
• North America largest market for professional acne treatments
• APAC to offer lucrative growth opportunities in future
• Market fragmented due to presence of numerous companies
The COVID-19 pandemic had a negative effect on the professional acne treatment market as almost all the cosmeticians and dermatologists were forced to down their shutters, to comply with the lockdown protocols. Similarly, companies that produce drugs and devices for acne treatment were non-operational or functional at a rather small scale, which reduced the supply and trade of the products. On the demand side, people were discouraged from spending on non-essential stuff as many were under immense financial stress.
The coming years will be characterized by the faster growth of the inflammatory bifurcation in the professional acne treatment market, on the basis of acne type. This kind of acne is considered severer than the non-inflammatory type, and it is often painful. Additionally, inflammatory acne cannot be cured by most of the drugs available over the counter (OTC), which is why a professional’s intervention is preferred.
The larger share in the treatment type segment of the professional acne treatment market in the past was held by the drugs bifurcation. Drugs are readily available, and treatment via them is less complex and costly than that carried out by devices.
Dermatologists are expected to dominate the professional acne treatment market in the near future, under segmentation by professional type. Compared to cosmeticians, dermatologists have a larger knowledge base and more experience in treating acne, which is why they remain popular among patients.
The market is being driven by the following factors:
• Rising Prevalence of Acne: Almost 90% of the people on earth, especially young adults and adolescents, get acne at some point in their lives. Moreover, the Global Burden of Disease study estimates the 2019 incidence of this common dermatological issue at 50 million cases in the U.S. alone.
• Adoption of Sedentary Lifestyle: This is another key driver for the professional acne treatment market as being less physically active leads to a rise in weight and the levels of lipids in the body. This, in turn, upsets the hormone concentration, which results in an array of skin diseases, including hormonal acne.
North America is the largest professional acne treatment market owing to the rising prevalence of this condition, increasing awareness on new drugs and devices, presence of many more drugs in the pipeline of pharma companies, such as Johnson & Johnson, Pfizer Inc., and Bausch Health Companies Inc., and high disposable income of the people of the continent.
The major players in the global professional acne treatment market are Galderma SA, Bausch Health Companies Inc., Johnson & Johnson, Pfizer Inc., Teva Pharmaceutical Industries Ltd., CHEPLAPHARM Arzneimittel GmbH, Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Bayer AG, Almirall S.A., Candela Corporation, Lumenis Ltd., Alma Lasers Ltd., Sciton Inc., Cutera Inc., EL.EN. S.p.a., Venus Concept Inc., Fotona d.o.o., Erchonia Corporation, and InMode Ltd.
Read the full report: https://www.reportlinker.com/p06180058/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
